MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

Although specific microRNA (miRNA) signatures in classical Hodgkin lymphoma (cHL) have been proposed, their relationship with clinical outcome remains unclear. Despite treatment advances, a substantial subset of patients with advanced cHL are refractory to standard therapies based on adriamycin and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Haematol
Asıl Yazarlar: Sánchez-Espiridión, Beatriz, Martín-Moreno, Ana M., Montalbán, Carlos, Figueroa, Vianihuini, Vega, Francisco, Younes, Anas, Medeiros, L. Jeffrey, Alvés, Francisco J., Canales, Miguel, Estévez, Mónica, Menarguez, Javier, Sabín, Pilar, Ruiz-Marcellán, María C., Lopez, Andrés, Sánchez-Godoy, Pedro, Burgos, Fernando, Santonja, Carlos, López, José L., Piris, Miguel A., Garcia, Juan F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291117/
https://ncbi.nlm.nih.gov/pubmed/23725219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12390
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller